Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
1.
Medicine (Baltimore) ; 100(32): e26832, 2021 Aug 13.
Artículo en Inglés | MEDLINE | ID: mdl-34397889

RESUMEN

ABSTRACT: Previous studies on hospital specialization in spinal joint disease have been limited to patients requiring surgical treatment. The lack of similar research on the nonsurgical spinal joint disease in specialized hospitals provides limited information to hospital executives.To analyze the relationship between hospital specialization and health outcomes (length of stay and medical expenses) with a focus on nonsurgical spinal joint diseases.The data of 56,516 patients, which were obtained from the 2018 National Inpatient Sample, provided by the Health Insurance Review and Assessment Service, were utilized. The study focused on inpatients with nonsurgical spinal joint disease and used a generalized linear mixed model with specialization status as the independent variable. Hospital specialization was measured using the Inner Herfindahl-Hirschman Index (IHI). The IHI (value ≤1) was calculated as the proportion of hospital discharges accounted for by each service category out of the hospital's total discharges. Patient and hospital characteristics were the control variables, and the mean length of hospital stay and medical expenses were the dependent variables.The majority of the patients with the nonsurgical spinal joint disease were female. More than half of all patients were middle-aged (40-64 years old). The majority did not undergo surgery and had mild disease, with Charlson Comorbidity Index score ≤1. The mean inpatient expense was 1265.22 USD per patient, and the mean length of stay was 9.2 days. The specialization status of a hospital had a negative correlation with the length of stay, as well as with medical expenses. An increase in specialization status, that is, IHI, was associated with a decrease in medical expenses and the length of stay, after adjusting for patient and hospital characteristics.Hospital specialization had a positive effect on hospital efficiency. The results of this study could inform decision-making by hospital executives and specialty hospital-related medical policymakers.


Asunto(s)
Tratamiento Conservador , Hospitales Especializados , Artropatías , Enfermedades de la Columna Vertebral , Tratamiento Conservador/economía , Tratamiento Conservador/métodos , Eficiencia Organizacional/normas , Femenino , Costos de Hospital , Hospitales Especializados/clasificación , Hospitales Especializados/estadística & datos numéricos , Humanos , Artropatías/economía , Artropatías/epidemiología , Artropatías/terapia , Tiempo de Internación/economía , Tiempo de Internación/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Evaluación de Necesidades , Alta del Paciente/estadística & datos numéricos , República de Corea/epidemiología , Índice de Severidad de la Enfermedad , Enfermedades de la Columna Vertebral/economía , Enfermedades de la Columna Vertebral/epidemiología , Enfermedades de la Columna Vertebral/terapia
2.
JAMA Netw Open ; 3(11): e2023515, 2020 11 02.
Artículo en Inglés | MEDLINE | ID: mdl-33136132

RESUMEN

Importance: Differences among pediatric transplant centers in long-term survival of pediatric recipients of heart transplants can be mostly explained by differences in 90-day mortality. Objective: To understand characteristics associated with high-performing pediatric HT centers by comparing key outcomes among centers stratified by 90-day risk-adjusted mortality. Design, Setting, and Participants: This retrospective cohort study included recipients of HT aged younger than 18 years in the US. Analyses included 44 US centers during 2006 to 2015 using the Organ Procurement and Transplant Network database. A risk model for 90-day mortality was developed using data from all recipients to estimate expected 90-day mortality and 90-day standardized mortality ratio (SMR; calculated as observed mortality divided by expected mortality) for each center. Centers were stratified into tertiles by SMR and compared for key outcomes. Data were analyzed from January to March 2020. Exposures: High-, medium-, and low-performing centers (SMR tertile). Main Outcomes and Measures: Posttransplant 90-day mortality across recipient risk spectrum and incidence of and mortality following early posttransplant complications. Results: Of 3211 children analyzed, 1016 (31.6%) were infants younger than 1 year and 1459 (45.4%) were girls. The median (interquartile range) age was 4 (0-12) years. Centers were stratified by SMR tertile, and SMR was 0 to 0.71 among 15 high-performing centers, 0.79 to 1.12 among 14 medium-performing centers, and 1.19 to 3.33 among 15 low-performing centers. High-performing centers had 90-day mortality of 0.8% (95% CI, 0.3%-1.8%) in children with low risk and expected mortality of 2.0%, 2.3% (95% CI, 0.6%-5.7%) in children with intermediate risk and expected mortality of 6.5%, and 16.7% (95% CI, 7.9%-29.3%) in children with high risk and expected mortality of 30.8%. Incidence of acute rejection during transplant hospitalization was 10.3% at high-performing centers, 10.3% at medium-performing centers, and 9.7% at low-performing centers (P for trend = .68), and incidence of post-HT kidney failure requiring dialysis was 4.1% at high-performing centers, 5.2% at medium-performing centers, and 8.5% at low-performing centers (P for trend = .001). Ninety-day mortality was significantly lower at high-performing centers among children treated for rejection (high-performing: 2.0%; medium-performing: 6.9%; low-performing: 11.7%; P for trend = .006) and among recipients receiving dialysis for post-HT kidney failure (high-performing: 17.5%; medium-performing: 39.4%; low-performing: 47.6%; P for trend < .001). Conclusions and Relevance: This cohort study found that high-performing pediatric HT centers had lower 90-day mortality across the recipient risk spectrum and lower mortality among recipients who develop rejection or post-HT kidney failure during transplant hospitalization. These findings suggest presence of superior processes and systems of care at high-performing pediatric HT centers.


Asunto(s)
Trasplante de Corazón/mortalidad , Hospitales Especializados/normas , Adolescente , Niño , Preescolar , Bases de Datos Factuales , Femenino , Hospitales Especializados/clasificación , Hospitales Especializados/estadística & datos numéricos , Humanos , Lactante , Masculino , Complicaciones Posoperatorias/mortalidad , Estudios Retrospectivos , Estados Unidos
4.
Curr Opin Organ Transplant ; 18(2): 229-34, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23385887

RESUMEN

PURPOSE OF REVIEW: There are more than 250 transplant centers in the USA, but variation continues to exist in organizational structure for transplant multidisciplinary services. We reviewed the literature to explore the definitions for transplant organizational structures and address existing rationale for the development of the integrated transplant service line. RECENT FINDINGS: No standard definitions exist to differentiate the use of program, center, institute, or service line. A survey of 20 multiorgan transplant centers in the USA showed that most were named centers or institutes, but some were organized as departments and service lines. The prevailing themes were the perceived need for autonomy of the transplant entity, alignment among services and finances, and the alignment of authority with responsibility. In addition, perceived benefits included growth, alignment, efficiency, and resource allocation. SUMMARY: The multidisciplinary nature of transplantation generally has been fit into the matrix organizational model, although many hospitals today have departments, centers, institutes, and service lines structures. Integration has been viewed as beneficial by most transplant entities reviewed, with a sense that it is better adapted for the evolving healthcare climate.


Asunto(s)
Hospitales Especializados/clasificación , Hospitales Especializados/organización & administración , Trasplante de Órganos , Humanos , Modelos Organizacionales , Asignación de Recursos , Estados Unidos
6.
JAMA ; 305(4): 373-80, 2011 Jan 26.
Artículo en Inglés | MEDLINE | ID: mdl-21266684

RESUMEN

CONTEXT: Although stroke centers are widely accepted and supported, little is known about their effect on patient outcomes. OBJECTIVE: To examine the association between admission to stroke centers for acute ischemic stroke and mortality. DESIGN, SETTING, AND PARTICIPANTS: Observational study using data from the New York Statewide Planning and Research Cooperative System. We compared mortality for patients admitted with acute ischemic stroke (n = 30,947) between 2005 and 2006 at designated stroke centers and nondesignated hospitals using differential distance to hospitals as an instrumental variable to adjust for potential prehospital selection bias. Patients were followed up for mortality for 1 year after the index hospitalization through 2007. To assess whether our findings were specific to stroke, we also compared mortality for patients admitted with gastrointestinal hemorrhage (n = 39,409) or acute myocardial infarction (n = 40,024) at designated stroke centers and nondesignated hospitals. MAIN OUTCOME MEASURE: Thirty-day all-cause mortality. RESULTS: Among 30,947 patients with acute ischemic stroke, 15,297 (49.4%) were admitted to designated stroke centers. Using the instrumental variable analysis, admission to designated stroke centers was associated with lower 30-day all-cause mortality (10.1% vs 12.5%; adjusted mortality difference, -2.5%; 95% confidence interval [CI], -3.6% to -1.4%; P < .001) and greater use of thrombolytic therapy (4.8% vs 1.7%; adjusted difference, 2.2%; 95% CI, 1.6% to 2.8%; P < .001). Differences in mortality also were observed at 1-day, 7-day, and 1-year follow-up. The outcome differences were specific for stroke, as stroke centers and nondesignated hospitals had similar 30-day all-cause mortality rates among those with gastrointestinal hemorrhage (5.0% vs 5.8%; adjusted mortality difference, +0.3%; 95% CI, -0.5% to 1.0%; P = .50) or acute myocardial infarction (10.5% vs 12.7%; adjusted mortality difference, +0.1%; 95% CI, -0.9% to 1.1%; P = .83). CONCLUSION: Among patients with acute ischemic stroke, admission to a designated stroke center was associated with modestly lower mortality and more frequent use of thrombolytic therapy.


Asunto(s)
Isquemia Encefálica/complicaciones , Hospitalización/estadística & datos numéricos , Hospitales Especializados/normas , Accidente Cerebrovascular/etiología , Accidente Cerebrovascular/mortalidad , Terapia Trombolítica/estadística & datos numéricos , Enfermedad Aguda , Anciano , Anciano de 80 o más Años , Femenino , Hemorragia Gastrointestinal/mortalidad , Hospitales Especializados/clasificación , Humanos , Masculino , Persona de Mediana Edad , Infarto del Miocardio/mortalidad , New York/epidemiología
7.
Hemoglobin ; 33 Suppl 1: S183-7, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-20001624

RESUMEN

From January 1998-July 2006, 62 stem cell transplantation (SCT) were performed on 60 patients with beta-thalassemia from HLA-related match donors. The overall survival (OS) and event free survival (EFS) for all patients were 94 and 77%. The outcome of allogeneic SCT in our experience is satisfactory with OS 92% and EFS 77%. Transplantation at a young age and when the disease is mild offers the best outcome. More advanced disease is associated with higher rate of rejection and severe graft versus host disease.


Asunto(s)
Trasplante de Células Madre Hematopoyéticas/métodos , Hospitales Especializados/clasificación , Talasemia beta/terapia , Rechazo de Injerto/inmunología , Enfermedad Injerto contra Huésped/inmunología , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Trasplante de Células Madre Hematopoyéticas/mortalidad , Humanos , Estudios Retrospectivos , Factores de Riesgo , Arabia Saudita , Análisis de Supervivencia , Resultado del Tratamiento , Talasemia beta/complicaciones , Talasemia beta/mortalidad
8.
BMC Health Serv Res ; 7: 155, 2007 Sep 25.
Artículo en Inglés | MEDLINE | ID: mdl-17894870

RESUMEN

BACKGROUND: The emergence of physician owned specialty hospitals focusing on high margin procedures has generated significant controversy. Yet, it is unclear whether physician owned specialty hospitals differ significantly from non physician owned specialty hospitals and thus merit the additional scrutiny that has been proposed. Our objective was to assess whether physician owned specialty orthopedic hospitals and non physician owned specialty orthopedic hospitals differ with respect to hospital characteristics and patient populations served. METHODS: We conducted a descriptive study using Medicare data of beneficiaries who underwent total hip replacement (THR) (N = 10,478) and total knee replacement (TKR) (N = 15,312) in 29 physician owned and 8 non physician owned specialty orthopedic hospitals during 1999-2003. We compared hospital characteristics of physician owned and non physician owned specialty hospitals including procedural volumes of major joint replacements (THR and TKR), hospital teaching status, and for profit status. We then compared demographics and prevalence of common comorbid conditions for patients treated in physician owned and non physician owned specialty hospitals. Finally, we examined whether the socio-demographic characteristics of the neighborhoods where physician owned and non physician owned specialty hospitals differed, as measured by zip code level data. RESULTS: Physician owned specialty hospitals performed fewer major joint replacements on Medicare beneficiaries in 2003 than non physician owed specialty hospitals (64 vs. 678, P < .001), were less likely to be affiliated with a medical school (6% vs. 43%, P = .05), and were more likely to be for profit (94% vs. 28%, P = .001). Patients who underwent major joint replacement in physician owned specialty hospitals were less likely to be black than patients in non physician owned specialty hospitals (2.5% vs. 3.1% for THR, P = .15; 1.8% vs. 6.3% for TKR, P < .001), yet physician owned specialty hospitals were located in neighborhoods with a higher proportion of black residents (8.2% vs. 6.7%, P = .76). Patients in physician owned hospitals had lower rates of most common comorbid conditions including heart failure and obesity (P < .05 for both). CONCLUSION: Physician owned specialty orthopedic hospitals differ significantly from non physician owned specialty orthopedic hospitals and may warrant the additional scrutiny policy makers have proposed.


Asunto(s)
Artroplastia de Reemplazo de Cadera/estadística & datos numéricos , Artroplastia de Reemplazo de Rodilla/estadística & datos numéricos , Hospitales Especializados/organización & administración , Ortopedia/organización & administración , Propiedad/clasificación , Anciano , Anciano de 80 o más Años , Áreas de Influencia de Salud , Comorbilidad , Femenino , Hospitales con Fines de Lucro , Hospitales Especializados/clasificación , Hospitales Especializados/estadística & datos numéricos , Hospitales de Enseñanza , Humanos , Revisión de Utilización de Seguros , Masculino , Medicare/estadística & datos numéricos , Ortopedia/estadística & datos numéricos , Médicos , Prevalencia , Características de la Residencia , Clase Social , Estados Unidos/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...